HIGHLIGHTS
- who: Qingwei Zhu from the Liver Disease Center, The Affiliated Hospital of Qingdao University, No, Haier Road, Qingdao, Shandong, Peopleu2019s Republic of China have published the Article: Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center, in the Journal: (JOURNAL) of December/31,/2021
- what: The authors attempted retrospectively analyzed clinical data and follow-up results of patients with recurrent HCC treated with regorafenib to identify the factors affecting the prognosis of these patients.
- how: All the patients were cared for in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.